researchers solve 1,500-year-old mystery: The bacterium behind the first pandemic
On Aug. 27, 2025, for the first time an interdisciplinary team at the University of South Florida (USF)…
Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64
On Aug. 27, 2025, Pfizer and BioNTech announced the U.S. Food and Drug Administration (FDA) has approved the…
Mexico reports 53% increase in flesh-eating screwworm cases since July
On Aug. 27, 2025, Mexico has recorded 5,086 cases of flesh-eating screwworm in animals as of August 17,…
Artificial Intelligence | Biotechnology | Genomics | Nanotechnology | Neurology | Non-Profit Research
Microsoft co-founder Paul Allen’s final act: New $3.1B foundation bets big on science and tech
On Aug. 27, 2025, a new fun created by Allen’s estate under the late Microsoft co-founder’s instructions, was…
new resource, MacroMap, provides a rich dataset that researchers can use to explore genetic mechanisms behind complex diseases
On Aug. 27, 2025, scientists from the Wellcome Sanger Institute reveal insights into how our genes influence the…
Aedes aegypti non-native mosquito detected in Oregon
On Aug. 26, 2025, health officials in Ashland, Oregon reported that six Aedes aegypti mosquitoes were found in…
Osivax Receives $19.5M BARDA Award to Advance Next-Generation Influenza Vaccine for Pandemic and Seasonal Preparedness
On Aug. 26, 2025, Osivax announced it has secured $19.5 million in funding from the Biomedical Advanced Research…
Valneva shares tumble after suspension of U.S. chikungunya vaccine license
On Aug. 25, 2025, shares of French drugmaker Valneva slumped more than 20% after the U.S. Food and…
AbbVie to Acquire Gilgamesh Pharma’s Investigational Therapy for Major Depressive Disorder for $1.2 Billion
On Aug. 25, 2025, AbbVie and Gilgamesh Pharmaceuticals announced a definitive agreement under which AbbVie will acquire Gilgamesh’s…
In a first, pig lung survives and functions—briefly—in a person
On Aug. 25, 2025, in a small step forward for the long-struggling field of xenotransplantation, surgeons in China…
Genentech and Roche Break Ground on State-of-the-Art Manufacturing Facility in Holly Springs, North Carolina
On Aug. 25, 2025, Genentech, a member of the Roche Group broke ground on its newest U.S. manufacturing site…
Tuskegee University breaks ground on $14 Million game-changing genomic research center
On Aug. 25, 2025, Tuskegee University cancer researchers gathered under two green tents to celebrate a day they…
MannKind to Acquire scPharmaceuticals for $360 million
On Aug. 25, 2025, MannKind and scPharmaceuticals announced the signing of a definitive merger agreement for MannKind to…
C2N Diagnostics Expands the PrecivityAD2™ Alzheimer’s Disease Blood Test Intended Use to Patients 50 Years and Older
On Aug. 25, 2025, C2N Diagnostics (C2N) announced lower age limit addresses increasing calls from clinicians seeking access…
Biotechnology | CDC | Diagnostics | Infectious Disease | NIH | Therapeutics | USDA
U.S. confirms nation’s first travel-associated human screwworm case connected to Central American outbreak
On Aug. 24, 2025, the U.S. Department of Health and Human Services reported the first human case in…
Award-winning HIV scientist Shan Liang leaves U.S. to join Chinese research institute
On Aug. 23, 2025, award-winning HIV scientist Shan Liang, a tenured associate professor at the Washington University School…
Mayo Clinic research set to launch aboard NASA mission to International Space Station to explore new therapies for bone loss
On Aug. 22, 2025, the Mayo Clinic announced that its pioneering exploration of stem cell-based therapies for bone…
MSDH Declares Public Health Emergency on Infant Mortality
On Aug. 21, 2025, the Mississippi State Department of Health (MSDH) declared a public health emergency in response…
Eliminating tobacco use could reduce age-related macular degeneration
On Aug. 21, 2025, the Institute for Health Metrics and Evaluation (IHME) announced a recent study aimed to…
Kite to Acquire Interius BioTherapeutics to Advance In Vivo Platform
On Aug. 21, 2025, Kite, a Gilead Company company, announced that it has entered into a definitive agreement…
Johnson & Johnson to Invest $2 Billion at State-Of-The-Art North Carolina Facility
On Aug. 21, 2025, Johnson & Johnson announced it will increase its presence in North Carolina with a…
Artificial Intelligence | Biotechnology | Diagnostics | Non-Profit Research | Oncology | Therapeutics
CPRIT Approves $27 Million In Grants for Cancer Research in Texas
On Aug. 20, 2025, The Cancer Prevention and Research Institute of Texas (CPRIT) announced the approval of 15…
New Method Advances Reliability of Ai with Applications in Medical Diagnostics
On Aug. 20, 2025, two studies led by Johns Hopkins Kimmel Cancer Center, Ludwig Center, and Johns Hopkins Whiting School of…
Biggest shake-up in type 2 diabetes care in a decade announced
On Aug. 20, 2025, the National Institute for Health and Care Excellence (NICE) announced that millions of people…
5th death linked to Legionnaires’ disease outbreak that has sickened dozens in New York City
On Aug. 19, 2025, health officials have uncovered another death in connection with a Legionnaires’ disease outbreak in…
Lewis and Clark County, Montana Health Officials Report First Measles Case in Decades
On Aug. 18, 2025, Lewis and Clark Public Health (LCPH) officlials in Montana have confirmed a single case…
In a Major Win for Vanda, a Federal Appeals Court Overturns FDA’s Order Denying Approval of Hetlioz for the Treatment of Jet Lag Disorder
On Aug. 18, 2025, Vanda Pharmaceuticals announced that it secured a landmark victory over the U.S. Food and…
Texas announces end of West Texas measles outbreak
On Aug. 18, 2025, the Texas Department of State Health Services is reporting the end of this year’s…
Skyhawk Therapeutics Announces Strategic Collaboration with Merck to Discover Novel RNA-Targeting Small Molecules for Neurological Disorders
On Aug. 18, 2025, Skyhawk Therapeutics announces a strategic research collaboration with Merck KGaA, Darmstadt, Germany. The collaboration…
Biotechnology | Disease | FDA | Medicine | Therapeutics
Novo Nordisk lowers cost of Ozempic® to $499 per month for self-paying patients
On Aug. 18, 2025, Novo Nordisk announced the launch of a new offer that enables self-paying, eligible, type…